Compound Information | |
---|---|
ID | 62 |
TrivialName | Notoginsenoside Ft1 |
Type | PPD |
MF | C₄₇H₈₀O₁₇ |
MolecularWeight | 917.14 |
IUPACName | (2S,3R,4S,5R)-2-[(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol |
m/z | 961.5369 |
Retention Time | 48.61 |
CCS | 324.28 |
Adducts | [M−H+HCOOH]− |
Isomeric SMILES | CC1(C)[C@@H](O[C@H]2[C@H](O[C@H]3[C@H](O[C@@H]4[C@@H](O)[C@H](O)[C@@H](O)CO4)[C@@H](O)[C@H](O)[C@@H](CO)O3)[C@@H](O)[C@H](O)[C@@H](CO)O2)CC[C@@]5(C)C1CC[C@]6(C)C5C[C@@H](O)C7[C@@]6(C)CCC7[C@@](C)(O[H])CC/C=C(C)/C |
Canonical SMILES | CC(C)=CCCC(C)(O)C1CCC2(C)C1C(O)CC1C3(C)CCC(OC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4OC4OCC(O)C(O)C4O)C(C)(C)C3CCC12C |
Source | PN |
Functions | hemostatic, anti-inflammatory, diabetic wound healing, anti-cancer, anti-obesity, anti-diabetes, hemostatic, anti-tumor, apoptotic, vasodilator, angiogenic |
Year | 2006 |
References | |
Structure |
|